Goldman Sachs’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$251K Sell
18,595
-1,716
-8% -$23.2K ﹤0.01% 4615
2025
Q1
$153K Buy
+20,311
New +$153K ﹤0.01% 4736